This podcast provides observations and commentary on the study by Payne and colleagues entitled 'Phase II Pilot Study of Intravenous High Dose Interferon with or without Maintenance Treatment in Melanoma at High Risk of Recurrence.'

Adjuvant High-Dose Interferon: New Evidence Regarding Treatment Duration and Survival Impact in Melanoma

The Journal of Clinical Oncology podcast, hosted by Dr. Shannon Westin and Dr. Davide Soldato, presents analyses and discussions centered on the latest findings published in ASCO's esteemed Journal of Clinical Oncology. Through scholarly discourse and examination, this podcast is your resource for navigating oncological advancements and how they impact clinical practice.

The JCO Podcast also features in depth summaries and interviews hosted by the year's fellows in the series, JCO Article Insights.

Medicine

Health & Fitness

The Journal of Clinical Oncology podcast, hosted by Dr. Shannon Westin and Dr. Davide Soldato, presents analyses and discussions centered on the latest findings published in ASCO's esteemed Journal of Clinical Oncology. Through scholarly discourse and examination, this podcast is your resource for navigating oncological advancements and how they impact clinical practice. The JCO Podcast also features in depth summaries and interviews hosted by the year's fellows in the series, JCO Article Insights.

Share Adjuvant High-Dose Interferon: New Evidence Regarding Treatment Duration and Survival Impact in Melanoma

Sign up to save your podcasts

Adjuvant High-Dose Interferon: New Evidence Regarding Treatment Duration and Survival Impact in Melanoma

Adjuvant High-Dose Interferon: New Evidence Regarding Treatment Duration and Survival Impact in Melanoma

More shows like Journal of Clinical Oncology (JCO) Podcast

NPR News Now

JAMA Editors' Summary

NEJM This Week

JAMA Clinical Reviews

ASCO Daily News

The Daily

ASCO Guidelines

ASCO Education

Annals On Call Podcast

JAMA Medical News

Harrison's PodClass: Internal Medicine Cases and Board Prep

Run the List

Two Onc Docs

Oncology Brothers: Practice-Changing Cancer Discussions

The Headlines